文献速递流行病学与生物统计医学教育与科研方法

核心结局指标集开发研究的系统评价:界定独特结局存在困难

A systematic review of core outcome set development studies demonstrates difficulties in defining unique outcomes.
PubMed 文献 · J Clin Epidemiol · 2019-07-02

结果显示多数研究未报告评估时点与分组方法,且无研究定义如何判定结局不同及确定最终独特结局数。作者提出独特结局需具备原始含义与情境,并建议将结局报告异质性(ORH)定义为跨试验报告与同一卫生保健状况相关的多个独特结局。

要点

  • COS开发文献对结局定义、提取、分组和计数方法不一致。
  • 仅32项(31.4%)研究报告评估时点,8项(7.8%)报告相似结局分组方法。
  • 无研究说明如何判定结局不同及确定最终独特结局数。

核心结论

  • COS开发研究中结局定义、提取、分组和计数方法存在不一致,需进一步完善所提定义以优化COS开发并实现ORH的可量化评估。

研究设计与样本

  • examining outcome numbers, definitions, timing, and grouping methodology.

主要发现

  • 82项(88.1%)研究报告了独特结局总数(中位数82;范围12-5776;IQR 261)。
  • 32项(31.4%)研究报告了评估时点,8项(7.8%)报告了相似结局分组方法。
  • 无研究定义如何将结局判定为不同及如何确定最终独特结局数。

关键数值与推荐

  • 提出独特结局需具备原始含义和情境。
  • 建议将ORH定义为跨试验报告与同一卫生保健状况相关的多个独特结局。

临床怎么用

  • COS开发时应明确报告结局的评估时点、分组方法及独特结局的判定标准。
  • 建议采用所提独特结局定义和ORH概念以促进结局报告异质性的量化评估。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Core outcome set (COS) development often begins with a systematic review to identify outcomes. Reviews frequently show heterogeneity in numbers of outcomes reported across trials. Contributing to this is a lack of a uniform definition for an outcome. This study proposes a first working definition for a unique trial outcome to support reporting a quantitative assessment of outcome reporting heterogeneity (ORH). STUDY DESIGN AND SETTING: Eligible COS literature (development papers, protocols, and reviews) were identified using the COMET database, Ovid MEDLINE, and PubMed. Outcome numbers, definitions, timing, and grouping methodology were examined. RESULTS: One hundred and thirty two studies were included. 82 (88.1%) studies (excluding protocols) reported a total number of unique outcomes (median, 82; range, 12-5776; IQR, 261). Timing of assessment was reported in 32 (31.4%) studies. Methods to group similar outcomes were reported in 8 (7.8%) articles. No study defined how outcomes were agreed as different and how final numbers of unique outcomes were determined. It is proposed that a unique outcome requires original meaning and context. Thus ORH is suggested to be the reporting of multiple unique outcomes across trials related to one health care condition. CONCLUSION: This review identified inconsistencies in how authors define, extract, group, and count trial outcomes. Further work is needed to refine our proposed definitions to optimize COS development and allow a quantifiable measure of ORH.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Young AE, Brookes ST, Avery KNL, et al. A systematic review of core outcome set development studies demonstrates difficulties in defining unique outcomes. J Clin Epidemiol. 2019. PMID: 31276780. doi:10.1016/j.jclinepi.2019.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。